Lymph node ratio as best prognostic factor in triple‐negative breast cancer patients with residual disease after neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

Lymph node ratio as best prognostic factor in triple‐negative breast cancer patients with residual disease after neoadjuvant chemotherapy

Published:2020-07-25 Issue:9 Volume:26 Page:1659-1666
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast J

Author:

De la Cruz‐Ku Gabriel A.¹²^ORCID,Chambergo‐Michilot Diego¹^ORCID,Valcarcel Bryan³^ORCID,Rebaza Pamela²,Möller Mecker⁴,Araujo Jhajaira M.⁵^ORCID,Enriquez Daniel⁶^ORCID,Morante Zaida⁶,Razuri Cesar⁷,Luque Renato¹,Saavedra Antonella¹,Eyzaguirre Eduardo¹,Lujan Maria¹,Noel Naysha¹,Pinto Joseph²^ORCID,Cotrina Jose⁴,Gomez Henry²⁸^ORCID

Affiliation:

1. Universidad Científica del Sur Lima Perú

2. Unidad de Investigación Básica y TranslacionalOncosalud‐AUNA Lima Peru

3. Milken Institute School of Public Health The George Washington University Washington DC USA

4. Division of Surgical Oncology University of Miami Miller School of Medicine Jackson Memorial Hospital/Sylvester Comprehensive Cancer Center Miami FL USA

5. Escuela de Medicina Humana Universidad Privada San Juan Bautista Lima Perú

6. Department of Hematology and Medical Oncology Instituto Nacional de Enfermedades Neoplasicas Lima Peru

7. Division of General Surgery Hospital Nacional Dos de Mayo Lima Peru

8. Department of Breast Surgical Oncology Instituto Nacional de Enfermedades Neoplasicas Lima Peru

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tbj.13988

Reference34 articles.

1. The Global Cancer Observatory.Peru. Source: Globocal 2018. In: Globocan [Internet]. WHO: Globocan 2018. Available from:https://gco.iarc.fr/today/data/factsheets/populations/604‐peru‐fact‐sheets.pdf

2. The Global Cancer Observatory.United States of America. Source: Globocal 2018. In: Globocan [Internet]. WHO: Globocan 2018. Available from:https://gco.iarc.fr/today/data/factsheets/populations/840‐united‐states‐of‐america‐fact‐sheets.pdf

3. Survival Study of Triple-Negative and Non–Triple-Negative Breast Cancer in a Brazilian Cohort

4. Eight year survival analysis of patients with triple negative breast cancer in India;Chandra D;Asian Pac J Cancer Prev,2016

5. Survival of triple negative versus triple positive breast cancers: comparison and contrast;Negi P;Asian Pac J Cancer Prev,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic disparities in young patients based on breast cancer subtype: A population-based study from the SEER database;Medicine;2023-03-31

2. The prognostic role of lymph node ratio in breast cancer patients received neoadjuvant chemotherapy: A dose-response meta-analysis;Frontiers in Surgery;2022-10-26

3. Nontherapeutic Risk Factors of Different Grouped Stage IIIC Breast Cancer Patients’ Mortality: A Study of the US Surveillance, Epidemiology, and End Results Database;The Breast Journal;2022-08-30

4. Potential prognostic value of the lymph node ratio and its correlation with circulating sex hormone concentration in pathological T1/2 breast cancer patients: a retrospective study;Annals of Translational Medicine;2022-05

5. Lymph Node Ratio as a Good Prognostic Factor for Patients with Pathologic N3a Breast Cancer with 10 or More Metastatic Axillary Lymph Nodes;Journal of Breast Disease;2021-12-31